DK367084D0 - Pyrrolo(1,2-a)imidazol og imidazo(1,2-a)pyridinimmunomodulatorer - Google Patents

Pyrrolo(1,2-a)imidazol og imidazo(1,2-a)pyridinimmunomodulatorer

Info

Publication number
DK367084D0
DK367084D0 DK367084A DK367084A DK367084D0 DK 367084 D0 DK367084 D0 DK 367084D0 DK 367084 A DK367084 A DK 367084A DK 367084 A DK367084 A DK 367084A DK 367084 D0 DK367084 D0 DK 367084D0
Authority
DK
Denmark
Prior art keywords
imidazo
pyridine
pyrrolo
imidazole
aryl
Prior art date
Application number
DK367084A
Other languages
English (en)
Other versions
DK367084A (da
Inventor
Thomas A Davidson
Robert J Murray
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of DK367084D0 publication Critical patent/DK367084D0/da
Publication of DK367084A publication Critical patent/DK367084A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK367084A 1983-07-29 1984-07-27 Pyrrolo(1,2-a)imidazol og imidazo(1,2-a)pyridinimmunomodulatorer DK367084A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/518,514 US4507481A (en) 1983-07-29 1983-07-29 Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines

Publications (2)

Publication Number Publication Date
DK367084D0 true DK367084D0 (da) 1984-07-27
DK367084A DK367084A (da) 1985-01-30

Family

ID=24064258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK367084A DK367084A (da) 1983-07-29 1984-07-27 Pyrrolo(1,2-a)imidazol og imidazo(1,2-a)pyridinimmunomodulatorer

Country Status (15)

Country Link
US (1) US4507481A (da)
EP (1) EP0150255B1 (da)
JP (1) JPS6042384A (da)
KR (1) KR910002837B1 (da)
AT (1) ATE59042T1 (da)
AU (1) AU562722B2 (da)
CA (1) CA1250295A (da)
DE (1) DE3483745D1 (da)
DK (1) DK367084A (da)
FI (1) FI78090C (da)
IL (1) IL71943A (da)
NO (1) NO161741C (da)
NZ (1) NZ208266A (da)
PH (1) PH19437A (da)
ZA (1) ZA844299B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4551535A (en) * 1983-07-29 1985-11-05 Pennwalt Corporation Process for preparing novel 7-thioester derivatives of 3H pyrrolo [1,2-a]-imidazole and 8-thioester derivatives of imidazo [1,2-a] pyridine
US4670445A (en) * 1984-03-05 1987-06-02 Eli Lilly And Company Inotropic agents
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
JPH06504779A (ja) * 1990-12-13 1994-06-02 スミスクライン・ビーチャム・コーポレイション 新規ｃｓａｉｄｓ
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
CA2134009C (en) 1993-11-11 2005-03-08 Oleg Werbitzky Bicyclic amidines, process for their preparation, and their use as catalyst
US5840732A (en) * 1994-06-20 1998-11-24 Takeda Chemical Industries Ltd. Imidazopyridine or imidazopyrimidine compounds, their production and use
US10738035B2 (en) 2015-05-13 2020-08-11 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017011552A1 (en) 2015-07-13 2017-01-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10301255B2 (en) 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017136403A1 (en) 2016-02-02 2017-08-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
EP3426245B1 (en) 2016-03-07 2022-12-14 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
BR112018075465A2 (pt) 2016-06-10 2019-03-19 Enanta Pharmaceuticals, Inc. agentes antivirais de hepatite b
KR102556744B1 (ko) 2017-08-28 2023-07-18 이난타 파마슈티칼스, 인코포레이티드 B형 간염 항바이러스제
WO2019113173A1 (en) 2017-12-06 2019-06-13 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10723733B2 (en) 2017-12-06 2020-07-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11058678B2 (en) 2018-01-22 2021-07-13 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US10729688B2 (en) 2018-03-29 2020-08-04 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
CA3113235A1 (en) 2018-09-21 2020-03-26 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
EP3883570A4 (en) 2018-11-21 2022-07-13 Enanta Pharmaceuticals, Inc. FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2020247575A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984665A (en) * 1958-05-14 1961-05-16 Rohm & Haas Condensed heterocyclic compounds
US4126685A (en) * 1975-01-31 1978-11-21 Imperial Chemical Industries Limited 6-Aryl-pyrrolo[1,2,9]imidazole derivatives which possess anti-hypertensive activity
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE59042T1 (de) 1990-12-15
IL71943A (en) 1987-07-31
NO161741C (no) 1989-09-20
NO843053L (no) 1985-01-30
EP0150255A3 (en) 1988-01-07
ZA844299B (en) 1985-01-30
JPS6042384A (ja) 1985-03-06
EP0150255B1 (en) 1990-12-12
FI78090B (fi) 1989-02-28
IL71943A0 (en) 1984-09-30
FI843001A (fi) 1985-01-30
KR850001210A (ko) 1985-03-16
EP0150255A2 (en) 1985-08-07
PH19437A (en) 1986-04-15
US4507481A (en) 1985-03-26
KR910002837B1 (ko) 1991-05-06
NZ208266A (en) 1987-03-31
DE3483745D1 (de) 1991-01-24
FI843001A0 (fi) 1984-07-27
NO161741B (no) 1989-06-12
DK367084A (da) 1985-01-30
AU2885284A (en) 1985-01-31
CA1250295A (en) 1989-02-21
FI78090C (fi) 1989-06-12
AU562722B2 (en) 1987-06-18

Similar Documents

Publication Publication Date Title
DK367084D0 (da) Pyrrolo(1,2-a)imidazol og imidazo(1,2-a)pyridinimmunomodulatorer
DK61491A (da) Pyrro(1,2-a)imidazol- og imidazo(1,2-a)pyridinderivater
ES8505658A1 (es) Procedimiento para preparar pirazol(aril)metanonas
AU576484B2 (en) Imidazolyl(1,5-a)pyridine derivatives
AU559666B2 (en) Imidazol (1,5-a)pyridines
NO930276D0 (no) Fremgangsmaate for fremstilling av imidazo(4,5-b)pyridin-derivater
MY103766A (en) Pyrrolo[1,2-a]imidazole and imidazo[1,2-a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
AU3237984A (en) Imidazo (1,5-a) (1,4) benzodiazepines
AU572237B2 (en) Imidazoline substituted pyrrolo (3,2,1-hi) indole derivatives
SE8400118D0 (sv) Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation
AU548784B2 (en) Imidazo(1,2-a)imidazole derivatives
AU621308C (en) Pyrrolo(1,2-a)imidazole and pyrrolo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
ZA886511B (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
AU564147B2 (en) Pyrrole, imidazole and 1,2,4-triazole derivatives
ES548684A0 (es) Procedimiento de preparacion de un derivado del imidazol
ES549793A0 (es) Nuevo procedimiento de obtencion de un derivado de imidazol
IE893261L (en) PYRROLO (1,2-a) IMIDAZOLES AND IMIDAZO (1,2-a) PYRIDINES

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment